Eton Pharmaceuticals to Report First Quarter 2026 Financial Results on Thursday, May 14, 2026

About this update from Eton Pharmaceuticals, Inc.

[{"type":"image","alt":"Eton Pharmaceuticals","displaySize":"","headline":null,"caption":"Eton Pharmaceuticals","className":"","disableSlideshowImg":false,"size":{"original":{"width":300,"height":86,"url":"https://media.zenfs.com/en/globenewswire.com/28f8553e49220b3671789b0841a3f340"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/wcuthC_koftYVXvofM_o3Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTQyMDtoPTEyMA--/https://media.zenfs.com/en/globenewswire.com/28f8553e49220b3671789b0841a3f340","width":300,"height":86}},"lazy":false},{"type":"text","content":"DEER PARK, Ill., May 04, 2026 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc (“Eton” or the “Company”) (Nasdaq: ETON), an innovative pharmaceutical company focused on developing and commercializing treatments for rare diseases, today announced that it will report first quarter 2026 financial results on Thursday, May 14, 2026. Management will host a conference call and live audio webcast to discuss the results at 4:30 p.m. ET (3:30 p.m. CT).","length":443,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"style":"max-width:20%;width:20%;min-width:20%;","val":[{"type":"text","content":"Participant Call Link:","length":22,"tagName":"p","attribs":{}}]},{"style":"max-width:80%;width:80%;min-width:80%;","val":[{"type":"text","content":"Click Here","length":10,"tagName":"p","attribs":{}}]}]},{"val":[{"val":[{"type":"text","content":" ","length":6,"tagName":"p"}]},{"val":[{"type":"text","content":" ","length":6,"tagName":"p"}]}]},{"val":[{"val":[{"type":"text","content":"Webcast:","length":8,"tagName":"p"}]},{"val":[{"type":"text","content":"Click Here","length":10,"tagName":"p"}]}]},{"val":[{"val":[{"type":"text","content":" ","length":6,"tagName":"p"}]},{"val":[{"type":"text","content":" ","length":6,"tagName":"p"}]}]}],"length":62},{"type":"text","content":"In addition to taking live questions from participants on the conference call, management will be answering emailed questions from investors. Investors can email questions to: [email protected] live webcast can also be accessed on the Investors section of Eton’s website at https://ir.etonpharma.com/. An archived webcast will be available on Eton’s website approximately two hours after the completion of the event and for 30 days thereafter.","length":464,"tagName":"p"},{"type":"text","content":"About Eton Pharmaceuti...

More updates from Eton Pharmaceuticals, Inc.